PIRAMAL PHARMA LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 157.2 INR | -0.15% |
|
+0.41% | +13.24% |
| 14/05 | Jefferies Adjusts Piramal Pharma’s Price Target to INR180 From INR170, Keeps at Buy | MT |
| 13/05 | Transcript : Piramal Pharma Limited, Q4 2024 Earnings Call, May 13, 2024 |
Evolution of the average Target Price on Piramal Pharma Limited
Price target over the last 5 years
History of analyst recommendation changes
1b26b39937c608326f6df4b0970.uj7P3HDhCsUzwt5FvqVOERv8J_hfzw7x4VO70jYn3bM.3WeKuR6wZ6wBkoEX8-0CUlyqX5cdt0vCrgLjg2V_v-nfauLsCIdlqWabmw~b996659e7140b51d01b12879f800e17c
More recommendations
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
157.2
INR
Average target price
178
INR
Spread / Average Target
+13.20%
High Price Target
190
INR
Spread / Highest target
+20.83%
Low Price Target
170
INR
Spread / Lowest Target
+8.11%
Consensus detail
Consensus revision (last 18 months)
Analysts covering Piramal Pharma Limited
| Jefferies & Co. |
Trading Rating
Investor Rating
ESG Refinitiv
EPS Revisions
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- PPLPHARMA Stock
- Consensus Piramal Pharma Limited
